# Phase 1 Safety Study of Recombinant Influenza Vaccine for Prevention

> **NCT02015494** · PHASE1 · UNKNOWN · sponsor: **VaxInnate Corporation** · enrollment: 316 (actual)

## Conditions studied

- Influenza

## Interventions

- **BIOLOGICAL:** VAX2012Q

## Key facts

- **NCT ID:** NCT02015494
- **Lead sponsor:** VaxInnate Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-03
- **Primary completion:** 2014-12
- **Final completion:** 2015-12
- **Target enrollment:** 316 (ACTUAL)
- **Last updated:** 2015-03-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02015494

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02015494, "Phase 1 Safety Study of Recombinant Influenza Vaccine for Prevention". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02015494. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*